Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial
This is an open-label trial evaluating feasibility, tolerability, safety and efficacy of psilocybin assisted cognitive processing therapy for chronic Posttraumatic Stress Disorder (PTSD).
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Unity Health Toronto
- Start date
- 2026-06-01
- End date
- 2027-01-01
- Registry ID
- NCT06386003
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.